EUVIMEDEUVIMED entdecken
Open Access

Characterization of CD3+/CD20+ canine large-cell lymphoma

Cory M Howard iD, Steffanie Anderson, Bonnie Harrington

Journal of Veterinary Diagnostic Investigation · 2024

DOI: 10.1177/10406387231204873 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Veterinary Diagnostic Investigation, 2024. Verfasst von Cory M Howard und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathobiology and Diagnostic Investigation, Michigan State University College of Veterinary Medicine, East Lansing, MI, USA. Hauptthemen laut MEDLINE: Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Peripheral, Dog Diseases. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: morris animal foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immunophenotyping of canine large-cell lymphoma (LCL) for B-cell and T-cell surface antigens is commonly performed to better predict the clinical outcome. Expression of surface antigen CD3 is associated with T-cell malignancies; surface antigen CD20 is expressed on B cells. However, a small subset of canine LCLs expresses both CD3 and CD20 (CD3+/CD20+); this form of lymphoma remains poorly defined at the molecular level. In a retrospective study, we aimed to better characterize immunophenotypic properties and antigen receptor clonality of CD3+/CD20+ LCL. We selected formalin-fixed, paraffin-embedded tissues from 10 cases of CD3+/CD20+ LCL and breed-matched controls of peripheral large T-cell lymphoma (PTCL) and diffuse large B-cell lymphoma (DLBCL). Using PCR for antigen receptor rearrangement (PARR), we identified monoclonal T-cell receptor gamma (TCRγ) rearrangements in all CD3+/CD20+ cases. Three of 10 cases had monoclonal rearrangements in the immunoglobulin heavy chain (IgH), supportive of cross-lineage rearrangement. There was no significant difference in the frequency of antigen receptor rearrangement between CD3+/CD20+ and PTCL cases. In comparison with DLBCL, CD3+/CD20+ LCL had TCRγ rearrangement more frequently and IgH rearrangement less frequently, respectively. Immunolabeling of the B-cell marker PAX5 occurred less frequently in all CD3+/CD20+ LCL cases compared to the DLBCL controls. Immunolabeling for BCL-2 was robust, regardless of immunophenotype. Nuclear Ki67 positivity was variable in CD3+/CD20+ cases, indicating a heterogeneity in proliferation. Overall, cases of canine CD3+/CD20+ LCL had properties similar to PTCL, suggesting a similar histogenesis of these 2 subsets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphoma, Large B-Cell, DiffuseLymphoma, T-Cell, PeripheralDog DiseasesAnimalsDogsRetrospective StudiesReceptors, AntigenAntigens, Surface

Stichwörter der Autor:innen

BCL-2CD20CD3DLBCLPARRPAX5PTCLcaninelarge-cell lymphoma

Substanzen

Receptors, AntigenAntigens, Surface

Autor:innen und Institutionen

  • Department of Pathobiology and Diagnostic Investigation, Michigan State University College of Veterinary Medicine, East Lansing, MI, USA.
  • Michigan State University Veterinary Diagnostic Laboratory, Lansing, MI, USA.
  • Charles River Laboratories, Mattawan, MI, USA.

ORCID-Profile: Cory M Howard

Förderung

  • morris animal foundation

Zitieren

APA

Howard, C. M., Anderson, S., & Harrington, B. (2024). Characterization of CD3+/CD20+ canine large-cell lymphoma. Journal of Veterinary Diagnostic Investigation. https://doi.org/10.1177/10406387231204873

Vancouver

Howard CM, Anderson S, Harrington B. Characterization of CD3+/CD20+ canine large-cell lymphoma. Journal of Veterinary Diagnostic Investigation. 2024. doi:10.1177/10406387231204873

BibTeX
@article{Howard2024,
  author = {Howard, Cory M and Anderson, Steffanie and Harrington, Bonnie},
  title = {Characterization of CD3+/CD20+ canine large-cell lymphoma},
  journal = {Journal of Veterinary Diagnostic Investigation},
  year = {2024},
  doi = {10.1177/10406387231204873}
}
Kostenlos starten →